- Home
- KOD vs MODV Comparison
KOD vs MODV Comparison
Compare KOD & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- MODV
- Stock Information
- Founded
- KOD 2009
- MODV 1996
- Country
- KOD United States
- MODV United States
- Employees
- KOD N/A
- MODV N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- MODV Transportation Services
- Sector
- KOD Health Care
- MODV Consumer Discretionary
- Exchange
- KOD Nasdaq
- MODV Nasdaq
- Market Cap
- KOD 186.3M
- MODV 172.6M
- IPO Year
- KOD 2018
- MODV N/A
- Fundamental
- Price
- KOD $5.33
- MODV $16.06
- Analyst Decision
- KOD Hold
- MODV Buy
- Analyst Count
- KOD 5
- MODV 4
- Target Price
- KOD $3.25
- MODV $27.25
- AVG Volume (30 Days)
- KOD 395.9K
- MODV 251.1K
- Earning Date
- KOD 11-26-2024
- MODV 11-06-2024
- Dividend Yield
- KOD N/A
- MODV N/A
- EPS Growth
- KOD N/A
- MODV N/A
- EPS
- KOD N/A
- MODV N/A
- Revenue
- KOD N/A
- MODV $2,787,619,000.00
- Revenue This Year
- KOD N/A
- MODV $4.32
- Revenue Next Year
- KOD N/A
- MODV $7.14
- P/E Ratio
- KOD N/A
- MODV N/A
- Revenue Growth
- KOD N/A
- MODV 3.16
- 52 Week Low
- KOD $1.90
- MODV $11.00
- 52 Week High
- KOD $7.77
- MODV $52.33
- Technical
- Relative Strength Index (RSI)
- KOD 76.60
- MODV 48.25
- Support Level
- KOD $3.73
- MODV $15.34
- Resistance Level
- KOD $5.58
- MODV $17.50
- Average True Range (ATR)
- KOD 0.28
- MODV 1.16
- MACD
- KOD 0.11
- MODV 0.17
- Stochastic Oscillator
- KOD 88.02
- MODV 26.29
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.